Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Menin-MLL

Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.

5 Items

per page
  1. MI-2
    A3602 MI-2
    Target: Menin-MLL
    Summary: Menin-MLL Inhibitor
      insoluble in H2O; ≥15.1 mg/mL
  2. MI-3
    A3603 MI-3
    Target: Menin-MLL
    Summary: Menin-MLL Inhibitor
      Soluble in DMSO
  3. MI-136
    B6166 MI-136
    Summary: menin-MLL interaction inhibitor
      Soluble in DMSO
  4. MI-nc (hydrochloride)
    C3379 MI-nc (hydrochloride)
    Summary: weak inhibitor of menin-MLL interaction
      ≤0.1 mg/mL
  5. MI-2 (hydrochloride)
    C3326 MI-2 (hydrochloride)
    Summary: menin-MLL interaction inhibitor
      ≤30 mg/mL

5 Items

per page
Relate Categories
Target
  1. Menin-MLL 2item
Reported Experiments
  1. Cell Experiments 2item
Related Disease
  1. Leukemia 1 item